PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma

1 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Childrens Oncology Group phase 1 consortium study The Lancet Oncology, April 24, 2013

2 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study The Lancet Oncology, May 3, 2013

3 Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response Cancer Immunology, Immunotherapy, April 22, 2013

4 Treatment With Topotecan Plus Cyclophosphamide in Children With First Relapse of Neuroblastoma Pediatric Blood & Cancer, May 15, 2013

5 Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors Pediatric Blood & Cancer, May 10, 2013

6 Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma Cancer Research, May 2, 2013

7 Acute Changes in Blood Pressure in Patients With Neuroblastoma Treated With 131I-Metaiodobenzylguanidine (MIBG) Pediatric Blood & Cancer, May 10, 2013    Review Article

8 Symptomatic Epidural Compression in Infants With Neuroblastoma: A Single-Center Experience With 5 Cases Journal of Pediatric Hematology/Oncology, May 3, 2013

9 Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target International Journal of Cancer, May 13, 2013

10 A NOTCH3 transcriptional module induces cell motility in neuroblastoma Clinical Cancer Research, May 8, 2013